Published in Adv Exp Med Biol on January 01, 1996
Fluctuations in endogenous kynurenic acid control hippocampal glutamate and memory. Neuropsychopharmacology (2011) 0.98
Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons. J Neural Transm (Vienna) (2005) 0.91
Kynurenic acid production in cultured bovine aortic endothelial cells. Homocysteine is a potent inhibitor. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.77
Kynurenic acid synthesis in bovine retinal slices--effect of glutamate agonists. J Neural Transm (Vienna) (2006) 0.77
Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science (1983) 2.79
The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci (2001) 2.61
Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci U S A (2001) 2.39
Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea. Nature (1976) 2.08
Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J Neurochem (1991) 2.01
Preferential neuronal loss in layer III of the entorhinal cortex in patients with temporal lobe epilepsy. Epilepsy Res (1993) 1.67
Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment Pharmacol Ther (2006) 1.58
Amino acid sequence of mouse nidogen, a multidomain basement membrane protein with binding activity for laminin, collagen IV and cells. EMBO J (1989) 1.51
Spontaneous NBT reduction by monocytes as a marker of disease activity in children with histiocytosis. Br J Haematol (1990) 1.45
Preferential neuronal loss in layer III of the medial entorhinal cortex in rat models of temporal lobe epilepsy. J Neurosci (1995) 1.42
Donors with a rare pheno (geno) type. Vox Sang (2008) 1.35
Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid. Neurosci Lett (1984) 1.29
Early degenerative changes in transgenic mice expressing mutant huntingtin involve dendritic abnormalities but no impairment of mitochondrial energy production. Exp Neurol (2001) 1.27
Treatment of recalcitrant ulcers with allogeneic platelet gel from pooled platelets in aged hypomobile patients. Biologicals (2011) 1.27
Excitotoxic models for neurodegenerative disorders. Life Sci (1984) 1.25
Characterization of surface layer proteins from different Clostridium difficile clinical isolates. Microb Pathog (2000) 1.23
Excitatory aminoacid antagonists provide a therapeutic approach to neurological disorders. Lancet (1985) 1.23
Fetal heart rate patterns in labors with intact and with ruptured membranes. J Perinat Med (1973) 1.23
3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum. Eur J Neurosci (1999) 1.23
Ibotenic acid-induced neuronal degeneration: a morphological and neurochemical study. Exp Brain Res (1979) 1.22
Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release. Eur J Neurosci (2009) 1.20
Modulation of cell surface-associated mannoprotein antigen expression in experimental candidal vaginitis. Infect Immun (1994) 1.16
Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women. Br J Clin Pharmacol (2006) 1.15
Antibodies to hepatitis C virus in Italian blood donors. Lancet (1989) 1.14
Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain? J Neural Transm (Vienna) (2006) 1.12
Identification and quantification of kynurenic acid in human brain tissue. Brain Res (1988) 1.12
Controlling the protein dynamical transition with sugar-based bioprotectant matrices: a neutron scattering study. Biophys J (2006) 1.12
Effect of caroxazone, a new antidepressant drug, on monoamine oxidases in healthy volunteers. Br J Clin Pharmacol (1981) 1.11
Quinolinic acid phosphoribosyltransferase in human and rat brain: activity in Huntington's disease and in quinolinate-lesioned rat striatum. Brain Res (1985) 1.10
Early kynurenergic impairment in Huntington's disease and in a transgenic animal model. Neurosci Lett (2000) 1.09
Characterization of rat brain kynurenine aminotransferases I and II. J Neurosci Res (1997) 1.08
A prospective study on children with initial diagnosis of transient hypogammaglobulinemia of infancy: results from the Italian Primary Immunodeficiency Network. Int J Immunopathol Pharmacol (2008) 1.08
Two kynurenine aminotransferases in human brain. Brain Res (1991) 1.07
Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum. Neuroscience (2008) 1.07
Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain. J Neurosci (1996) 1.06
Ineffective expression of CD40 ligand on cord blood T cells may contribute to poor immunoglobulin production in the newborn. Eur J Immunol (1994) 1.06
Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci Lett (1989) 1.05
Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum. Nature (1978) 1.03
Rat brain slices produce and liberate kynurenic acid upon exposure to L-kynurenine. J Neurochem (1989) 1.02
Description and preliminary evaluation of a new ultrasonic atomizer for spray-congealing processes. Int J Pharm (1999) 1.01
Purification and characterization of kynurenine-pyruvate aminotransferase from rat kidney and brain. Brain Res (1990) 1.00
The critical role of the proximal calcium ion in the structural properties of horseradish peroxidase. J Biol Chem (2001) 1.00
Age-related changes in kynurenic acid production in rat brain. Brain Res (1992) 1.00
Saquinavir induces stable and functional expression of the multidrug transporter P-glycoprotein in human CD4 T-lymphoblastoid CEMrev cells. HIV Med (2003) 1.00
Differential vulnerability of central neurons of the rat to quinolinic acid. Neurosci Lett (1983) 1.00
Neuronal localization of specific brain phosphoproteins. Brain Res (1978) 0.99
E-learning tools for education: regulatory aspects, current applications in radiology and future prospects. Radiol Med (2008) 0.99
Molecular cloning and functional expression of human 3-hydroxyanthranilic-acid dioxygenase. J Biol Chem (1994) 0.98
Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126. Biochem J (1999) 0.98
Kynurenate production by cultured human astrocytes. J Neural Transm (Vienna) (2003) 0.97
Skin wound healing: some biochemical parameters in guinea-pig. J Pharm Pharmacol (1993) 0.97
Striatal lesions with kainic acid: neurochemical characteristics. Brain Res (1977) 0.97
1H NMR-visible mobile lipid domains correlate with cytoplasmic lipid bodies in apoptotic T-lymphoblastoid cells. Biochim Biophys Acta (2001) 0.97
Inhibition of candidacidal activity of human neutrophil leukocytes by aminoglycoside antibiotics. Antimicrob Agents Chemother (1980) 0.97
Blood acid-base balance at birth in neonates from labors with early and late rupture of membranes. J Pediatr (1976) 0.97
Synthesis of quinolinic acid by 3-hydroxyanthranilic acid oxygenase in rat brain tissue in vitro. J Neurochem (1986) 0.96
Metabolism of [5-3H]kynurenine in the rat brain in vivo: evidence for the existence of a functional kynurenine pathway. J Neurochem (1995) 0.95
Quinolinic acid phosphoribosyltransferase: purification and partial characterization from human liver and brain. J Biochem (1988) 0.95
Invited article: Coherent imaging using seeded free-electron laser pulses with variable polarization: first results and research opportunities. Rev Sci Instrum (2013) 0.95
Mind glue: implications of glial cell biology for psychiatry. Arch Gen Psychiatry (2000) 0.94
Mitochondrial electron transport and glycolysis are coupled in articular cartilage. Osteoarthritis Cartilage (2012) 0.94
Molecular cloning of rat kynurenine aminotransferase: identity with glutamine transaminase K. FEBS Lett (1994) 0.94
On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compounds. Neuropharmacology (1983) 0.94
Characterization of quinolinic acid phosphoribosyltransferase in human blood and observations in Huntington's disease. J Neurochem (1985) 0.94
Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride. Metabolism (1999) 0.93
Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo. Neuroscience (2000) 0.93
Identification of quinolinic acid in rat and human brain tissue. Neurosci Lett (1983) 0.93
Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry. Neuroscience (2010) 0.93
Italian experience with AutoCapture in conjunction with a membrane lead. Pacesetter Automatic Control of Energy and Membrane Automatic Threshold Evaluation (Pacemate) Study Group. Pacing Clin Electrophysiol (1996) 0.93
Purification of quinolinic acid phosphoribosyltransferase from rat liver and brain. Biochim Biophys Acta (1985) 0.92
Targeting Id protein interactions by an engineered HLH domain induces human neuroblastoma cell differentiation. Oncogene (2009) 0.92
Quinolinic acid phosphoribosyltransferase in rat brain. J Neurochem (1985) 0.92
Biophysical and structural characterization of 1H-NMR-detectable mobile lipid domains in NIH-3T3 fibroblasts. Biochim Biophys Acta (1999) 0.92
Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain. J Neural Transm (Vienna) (2006) 0.92
[Endosteal hyperostosis with recessive transmission (Van Buchem's disease). A case report]. Recenti Prog Med (1991) 0.91
Post-mortem high affinity glutamate uptake in human brain. Neuroscience (1982) 0.91
Brain-specific modulation of kynurenic acid synthesis in the rat. J Neurochem (1997) 0.91
PIPPin is a brain-specific protein that contains a cold-shock domain and binds specifically to H1 degrees and H3.3 mRNAs. J Biol Chem (1999) 0.91
Chronic infusion of endogenous excitatory amino acids into rat striatum and hippocampus. Brain Res Bull (1983) 0.91
Measurement of rat brain kynurenine aminotransferase at physiological kynurenine concentrations. J Neurochem (1991) 0.91
Intracellular localization of the antitumour drug adriamycin in living cultured cells: a confocal microscopy study. J Microsc (1994) 0.91
D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis. Thromb Haemost (2011) 0.91
Indole-3-propionate: a potent hydroxyl radical scavenger in rat brain. Brain Res (1999) 0.90
Variable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood. J Thromb Haemost (2011) 0.90
Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence. J Thromb Haemost (2005) 0.90
Two-colour pump-probe experiments with a twin-pulse-seed extreme ultraviolet free-electron laser. Nat Commun (2013) 0.90
Thermodynamics of the high-affinity interaction of TCF4 with beta-catenin. J Mol Biol (2001) 0.90
Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: reversal with galantamine. Neuroscience (2013) 0.90
Comparative effects of estradiol benzoate, the antiestrogen clomiphene citrate, and the progestin medroxyprogesterone acetate on kainic acid-induced seizures in male and female rats. Epilepsia (1985) 0.90
High-affinity uptake of L-kynurenine by a Na+-independent transporter of neutral amino acids in astrocytes. J Neurosci (1989) 0.90
Fingerprints of amorphous icelike behavior in the vibrational density of states of protein hydration water. Phys Rev Lett (2008) 0.90
Clinical, neuropathologic and pharmacologic aspects of Huntington's disease: correlates with a new animal model. Prog Neuropsychopharmacol (1977) 0.89
Methylamine and benzylamine induced hypophagia in mice: modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels. Br J Pharmacol (2001) 0.89
Microinjection of kainic acid into the rat hippocampus. Eur J Pharmacol (1978) 0.89
Cloning of rat and human kynurenine aminotransferase. Adv Exp Med Biol (1996) 0.89
Management of alloimmune thrombocytopenia. Vox Sang (2007) 0.89
N-Formylmethionyl-leucyl-phenylalanine: Different releasing effects on human neutrophils and rat mast cells. Agents Actions (1983) 0.89